• Industry
  • Finance
  • Culture
  • Politics
  • Science
  • Wellness
  • Industry
  • Finance
  • Culture
  • Politics
  • Science
  • Wellness
Trump’s Psychedelic Fast-Track Order Changes the Timeline. It Also Redraws the Competitive Map.
AbbVie Withdraws Patent Challenge, Clearing Path for Enveric’s Psychedelic IP Strategy
Breaking: Enveric Reports New Mechanistic Data Supporting Non-Hallucinogenic Neuroplastogen Strategy
Two New Studies Are Rewriting the Rules of Psychedelic Drug Development
Starting 2026: Why Neuroplastogens Are Quietly Redefining the Psychedelic Medicine Narrative
Psychedelics in 2025: A Year of Proof, Pullback, and a Clearer Path Forward
Delix Therapeutics Reports Strong Phase Ib Results
Childhood Trauma’s Role in Men’s Substance Use Disorders
Human-Centered AI in Healthcare
Enveric Biosciences Doubles Down on IP Strength as Psychedelic Biotech Sector Heats Up
Shop

Dr. Dennis McKenna to Host Historic Livestream Psychoactive Symposium

Microdose by Microdose
May 16, 2022
in Press Releases
Reading Time: 2 mins read
A A
Dr. Dennis McKenna to Host Historic Livestream Psychoactive Symposium

Dr. Dennis McKenna to Host Historic Livestream Psychoactive Symposium

 

On the 55th-year anniversary of the original program presented by the United States government in 1967, the McKenna Academy of Natural Philosophy hosts its first Ethnopharmacologic Search for Psychoactive Drugs (ESPD55) event on May 23-26th, 2022. Viewed by hundreds of thousands when it was held in 2017 (ESPD50), this year’s event is carefully curated by Dr. Dennis McKenna and includes over 30 sessions exploring the potential of ethnopharmacology for humanity.

Livestreams will span a four-day program organized by life-centric themes or Spheres: ARCHAEOSPHERE, ETHNOSPHERE, FAUNASPHERE, HYDROSPHERE, MYCOSPHERE, NEUROSPHERE, PHYTOSPHERE, SOCIOSPHERE, SONOSPHERE. Esteemed speakers include Monica Gagliano, Mark Plotkin, Elaine Elisabetsky, Andrew Weil, Wade Davis, Paul Stamets and David Nutt. They will be joined by other innovators convening in the UK at St. Giles House in Dorset. Topics on the program include how psychedelics can change the future of mental health therapy, how ancestral knowledge can inform scientific discovery, what sustainability means to plant medicines, and other relevant areas in psychoactive study.

The Academy will also premiere its first documentary: BioGnosis: Bridges to

Lasix Medicine For Sale

Continue on your trip...

AbbVie’s $1B Psychedelic Bet: Who’s Next in the Neuroplastogen Gold Rush?

Enveric’s Latest Patent Signals a Clear Path Forward for PTSD Drug Development

Enveric’s EB-003 Shows Promise in PTSD Model, Offering a New Direction in Trauma Treatment

 Ancestral Wisdom. The film follows an Academy project to preserve precious and therapeutic plants at risk of extinction at a vital facility in the jungles of Peru. Called the Herbarium Amazonense, it not only houses close to 160K specimens, they’re all being digitized to serve generations to come.

[bsa_pro_ad_space id=2]
ADVERTISEMENT

The symposium begins at 09:00 on the 23rd of May and finishes at 20:00 on the 26 of May (GMT).

Admission to the livestream is by minimum contribution of $10. All are welcome.

Contact: espd@mckenna.academy

https://espd55.com/

https://espd55.com/

[bsa_pro_ad_space id=2]
ADVERTISEMENT
Microdose

Microdose

At our core, we champion integrity, diversity, and objectivity, providing trusted content that unites a wide array of experts and fosters unbiased opinions, ultimately empowering the psychedelic medicine community to flourish and make a positive impact on the world.

Next Post
Plant Medicine Week 2022: European Psychedelic Clinics and Retreats

Plant Medicine Week 2022: European Psychedelic Clinics and Retreats

Please login to join discussion

Who do you think will be first to successfully develop a psychedelic drug?
This field is for validation purposes and should be left unchanged.

Latest News

Trump’s Psychedelic Fast-Track Order Changes the Timeline. It Also Redraws the Competitive Map.

AbbVie Withdraws Patent Challenge, Clearing Path for Enveric’s Psychedelic IP Strategy

Breaking: Enveric Reports New Mechanistic Data Supporting Non-Hallucinogenic Neuroplastogen Strategy

ADVERTISEMENT

Follow us on social

Microdose is your guide to psychedelics. Our mission is to shift the world’s perception of psychedelic medicine.

Read the News
  • Industry
  • Culture
  • Science
  • Finance
  • Law & Politics
  • Health & Wellness
  • Industry
  • Culture
  • Science
  • Finance
  • Law & Politics
  • Health & Wellness
Online Courses
  • Microdosing
  • MDMA
  • Ketamine
  • Psychedelic Counseling
  • Addiction Treatment
  • Classic Psychedelics
  • Microdosing
  • MDMA
  • Ketamine
  • Psychedelic Counseling
  • Addiction Treatment
  • Classic Psychedelics
Subscribe for Exclusive Updates

Terms & Conditions / Privacy Policy

© 2026 MD Media Inc. All rights reserved. The information provided on this website does not, and is not intended to, constitute financial, legal or medical advice. All information, content, and materials available on this site are for general educational and informational purposes only.

WordPress Ads
No Result
View All Result
  • Landing Page
  • Buy JNews
  • Support Forum
  • Contact Us

© 2026 JNews - Premium WordPress news & magazine theme by Jegtheme.